Newsletter - Turenne Groupe

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Groupe Vigier organizes its transfer with the support of Nov Relance Impact, managed by Turenne Groupe

Turenne Groupe is proud to support the EPSA Group in financing its external growth.

Société Générale Capital Partenaires (SGCP), Ouest Croissance, Bpifrance and Turenne Groupe renew their confidence in Demgy Group, european [...]

PhysioAssist announces successful acquisition by Inogen Inc. to accelerate Simeox’ US market reach and beter serve a larger population of [...]

Turenne Groupe launches the Next Health Capital fund and boosts its teams dedicated to healthcare innovation

Domain Therapeutics raises $42m Series A financing

GERMITEC pursues its ambitious business expansion with a financing round of €11 million from leading French investors in the health sector

StromaCare has raised €1,500,000 for the development of a new oncology therapy based on the immuno-modulation of the tumor stroma using a [...]

Phodé, a laboratory specialising in natural sensory solutions, reorganised its share capital with the entry of Turenne Santé as a minority [...]

Turenne Santé, supported by BNP Paribas Développement, becomes a minority shareholder in the capital of H.A.C.Pharma to support the company in its [...]

Innovacom acquires a stake in Primo1D, world leader in smart electronic thread

AI Verse raises 2.5 million euros from Innovacom and Bpifrance

SUBSCRIBE TO NEWSLETTER

PLEASE ENTER YOUR EMAIL ADDRESS

Latest news